KP-1019

Known as: KP 1019, KP1019 
 

Topic mentions per year

Topic mentions per year

1997-2017
024619972017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The cellular uptake and subcellular distribution including adduct formation with genomic DNA and uptake into mitochondria of two… (More)
  • figure 1
Is this relevant?
2010
2010
The ruthenium compound KP1019 has demonstrated promising anticancer activity in a pilot clinical trial. This study aims to… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2010
2010
The binding of the ruthenium-based anticancer drug candidates KP1019, NAMI-A and RAPTA-T towards different double-stranded… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2009
2009
A phase I and pharmacokinetic study was carried out with the new ruthenium complex indazolium trans-[tetrachlorobis(1H-indazole… (More)
Is this relevant?
2009
2009
Cellular uptake is being widely investigated in the context of diverse biological activities of metal compounds on the cellular… (More)
Is this relevant?
2005
2005
The Ru(III) complex salt KP1019 induced formation of H2O2 in colorectal tumor cells in a dose-dependent way. It also caused DNA… (More)
Is this relevant?
2005
2005
KP1019 [indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A) is a metal complex with promising anticancer… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
2004
2004
The ruthenium complex salt indazolium trans-[tetrachlorobisindazole-ruthenate(III)] (KP1019) and the analogous sodium salt KP1339… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
1998
1998
The nephrotoxicity of three platinum (CPL, KP734, KP735) and three ruthenium coordination complexes (KP418, KP692, KP1019) was… (More)
Is this relevant?
1997
1997
Trans-indazolium[tetrachlorobisindazoleruthenate(III)] (KP 1019) is a new heavy metal complex with promising activity against… (More)
Is this relevant?